Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the page's documentation.
    Difference
    0.1%
    Check dated 2026-06-05T11:46:17.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.3 to v3.5.4, indicating a newer build of the page. No user-facing content or study data were altered.
    Difference
    0.1%
    Check dated 2026-05-15T04:17:39.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.3, updating the prior revision tag from v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-30T19:10:40.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:18:09.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Updated eligibility criteria now allow concurrent hormonal or anti-HER2 therapy if brain metastases progress; MRI criteria were revised to require at least 2 untreated measurable brain metastases (≥3 mm) within two weeks before treatment, and prior subtotal resection is permitted if residual disease <4 cm.
    Difference
    0.5%
    Check dated 2026-04-02T05:42:46.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Site revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:21:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.